Mindray Medical International Limited, commonly known as Mindray, is a leading global provider of medical devices and solutions, headquartered in Shenzhen, China. Founded in 1991, the company has established a strong presence in over 190 countries, focusing on key operational regions such as North America, Europe, and Asia. Specialising in the development of innovative medical technologies, Mindray's core business areas include patient monitoring and life support, in-vitro diagnostics, and medical imaging. The company is renowned for its high-quality products, such as advanced ultrasound systems and versatile anaesthesia machines, which are distinguished by their reliability and user-friendly design. With a commitment to enhancing healthcare delivery, Mindray has achieved significant milestones, including numerous industry awards and recognitions. As a prominent player in the medical device industry, Mindray continues to drive advancements that improve patient outcomes and streamline clinical workflows.
How does Mindray Medical International Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Mindray Medical International Limited's score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Mindray Medical International Limited, headquartered in China (CN), has made notable strides in reducing its carbon emissions, particularly in Scope 2 emissions. In 2023, the company achieved an 8.51% decrease in carbon emission intensity compared to 2022. This reduction reflects Mindray's commitment to enhancing energy efficiency and minimising its environmental impact. Currently, there is no specific data available regarding absolute carbon emissions in kg CO2e for the most recent year. However, the company's focus on reducing carbon intensity indicates a proactive approach to climate commitments. Mindray has not set specific Science-Based Targets (SBTi) or other formal climate pledges, but the ongoing reduction initiatives demonstrate a commitment to sustainability. As Mindray continues to implement strategies aimed at reducing its carbon footprint, it remains focused on improving its operational efficiency and contributing to global climate goals.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Mindray Medical International Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.